Pathway Financial Advisors’s Pfizer PFE Stock Holding History

Pathway Financial Advisors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-3,994	Closed	-$205K	–	135
2022 Q4	$205K	Sell	3,994 -2,408	-38%	-$115K	0.06%	120
2022 Q3	$280K	Buy	6,402 +400	+7%	+$19.4K	0.1%	98
2022 Q2	$315K	Buy	6,002 +1,051	+21%	+$53.6K	0.13%	89
2022 Q1	$256K	Buy	4,951 +90	+2%	+$4.67K	0.1%	117
2021 Q4	$256K	Buy	+4,861	New	+$241K	0.09%	116
2021 Q1	$541K	Sell	13,489 -1,000	-7%	-$35.5K	0.21%	54
2020 Q4	$485K	Sell	14,489 -3,989	-22%	-$146K	0.2%	55
2020 Q3	$638K	Buy	18,478 +7,289	+65%	+$256K	0.25%	39
2020 Q2	$347K	Sell	11,189 -2,651	-19%	-$90.1K	0.1%	61
2020 Q1	$442K	Hold	13,840	–	–	0.15%	45
2019 Q4	$530K	Buy	13,840 +5,481	+66%	+$195K	0.15%	57
2019 Q3	$294K	Hold	8,359	–	–	0.08%	74
2019 Q2	$344K	Sell	8,359 -124	-1%	-$4.92K	0.1%	66
2019 Q1	$342K	Buy	8,483 +719	+9%	+$28.8K	0.11%	67
2018 Q4	$322K	Hold	7,764	–	–	0.18%	68
2018 Q3	$320K	Hold	7,764	–	–	0.18%	69
2018 Q2	$267K	Hold	7,764	–	–	0.16%	70
2018 Q1	$261K	Buy	7,764 +106	+1%	+$3.64K	0.15%	67
2017 Q4	$263K	Buy	+7,658	New	+$261K	0.15%	70

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Pathway Financial Advisors's PFE Position: Q1 2023 in Review

Pathway Financial Advisors sold out of Pfizer (PFE) in Q1 2023, closing a stake of 3,994 shares — an estimated $205K sold.

Pathway Financial Advisors first reported a position in PFE in Q4 2017 and held it in 19 quarters. The position peaked at $638K in Q3 2020. 3,102 funds tracked by Wall St. Rank hold PFE as of Q1 2023.

Pathway Financial Advisors reported no remaining Pfizer position as of Q1 2023 after selling out during the quarter.
Pathway Financial Advisors sold 3,994 Pfizer shares in Q1 2023, an estimated $205K.
Pathway Financial Advisors first reported a position in Pfizer in Q4 2017 and held it in 19 quarters.
Pathway Financial Advisors's Pfizer position peaked at $638K in Q3 2020.
3,102 funds tracked by Wall St. Rank held Pfizer as of Q1 2023.

Based on Pathway Financial Advisors's 13F filing for Q1 2023, filed 28 Apr 2023.